Month: April 2021

BETHESDA, Md., April 12, 2021 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ:LQDT), the world’s largest B2B e-commerce marketplace for business and government surplus, announced today that it will report the results of its second quarter fiscal year 2021 ended March 31, 2021 on Thursday, May 6, 2021 at 10:30 a.m. Eastern Time. The earnings press release will be distributed prior to market open on the same day. Bill Angrick, Chairman and CEO, and Jorge Celaya, EVP and CFO, will host the earnings event. Investors and other interested parties may access the teleconference by dialing (888) 771-4371 or (847) 585-4405 and providing conference ID 50121689. A live web cast of the conference call will be provided on the Company’s investor relations website at http://investors.liquidityservices.com. An archive of the web cast will be available...

VANCOUVER, British Columbia, April 12, 2021 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (TSX: EDR, NYSE: EXK) (“Endeavour”) announces that it has now closed the sale of the El Cubo Mine in Guanajuato, Mexico to VanGold Mining Corp. (“VanGold”) for $15 million in cash and share payments plus up to $3 million in future contingent payments (all dollar amounts in US dollars unless otherwise noted) (the “Transaction”). VanGold paid $15,000,000 to Endeavour as follows:$7.5 million cash on closing. $5.0 million (C$6,399,317.40) in VanGold common shares (“VanGold Shares”) on closing, priced at $0.2344 (C$0.30) per VanGold Share for a total of 21,331,058 VanGold Shares (“Consideration Shares”) representing approximately 10.9% of the issued and outstanding VanGold Shares. $2.5 million promissory note due 12 months from closing.VanGold has...

Clinical and pathological data presented from the clinical trials of Bria-IMT™ alone and in combination with immune checkpoint inhibitors in advanced breast cancer indicates high responding subset with protracted progression-free survival:Data suggests a link with cancer grade, disease control, and progression-free-survival in patients treated with Bria-IMT™. Highest rate of disease control and longest progression free survival were observed in patients with Grade I/II tumors. Median overall survival of 12.5 months in patients with Grade I/II tumors versus 7.2-9.8 months in a recent study of third line breast cancer.BERKELEY, Calif. and VANCOUVER, British Columbia, April 12, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company...

BEIJING, April 12, 2021 (GLOBE NEWSWIRE) — Kaixin Auto Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) today announced that Haitaoche Limited (“Haitaoche”) has signed into a cooperation agreement (“Cooperation Agreement”) with Jingdong Century Trade Limited (“Jingdong”), a leading online retail platform (www.jd.com) in China to tap into China’s fast-growing e-commerce auto market. Kaixin entered into a definitive share purchase agreement with the shareholders of Haitaoche on December 31, 2020, pursuant to which Kaixin will acquire 100% of the share capital of Haitaoche from the shareholders of Haitaoche.1 According to the terms of the Cooperation Agreement, Haitaoche aims to gain access to China’s fast-growing e-commerce auto sales market and tap into diversified revenue source and growth opportunities by leveraging its rich...

SOUTH SAN FRANCISCO and SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of resistance in cancer, presented four preclinical poster presentations at the 2021 American Association for Cancer Research (AACR) virtual annual meeting. ORIC-101: Glucocorticoid Receptor (GR) AntagonistORIC-101 is a potent and selective GR antagonist, with two distinct mechanisms of action being evaluated in two Phase 1b trials in combination with: (1) Abraxane (nab-paclitaxel) in advanced or metastatic solid tumors and (2) Xtandi (enzalutamide) in metastatic prostate cancer. Key findings of the presentation:GR upregulation and activation, an established resistance mechanism for antiandrogens, may drive resistance when antiandrogens...

AVENTURA, Fla., April 12, 2021 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that Robert Grinberg, President, Chief Executive Officer and Chairman, has issued a letter to Life Clips’ shareholders. The full text is as follows: To My Fellow Stockholders, Over the course of the last few months, Life Clips, Inc. has made significant progress in advancing its strategic plan and we are off to a tremendous start. First, I am proud to report that Life Clips is current in its status as a fully reporting company with the SEC. This took many months of hard work by our CFO and her team of professionals. One of our primary goals moving forward will be corporate transparency. I am a firm believer that transparency pays off in the financial markets in the form of less risk to investors and a lower cost...

AFM24 induces strong tumor cell killing independent of KRAS mutations AFM24, in combination with adoptive NK cells, leads to dose-dependent tumor regressionHeidelberg, Germany, April 12, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announces pre-clinical data on its Innate Cell Engager (ICE®) AFM24 as monotherapy and in combination with adoptively transferred NK cells at the American Association for Cancer Research (AACR) Virtual Annual Meeting I. AFM24, an EGFR/CD16A-binding ICE®, mediates antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) and has the potential to overcome toxicity and resistance hurdles associated with current EGFR signaling inhibitors through its differentiated...

Luleå, 2021-04-12 — Effnet, a subsidiary of Effnetplattformen AB and a leading provider of 5G protocol stack software for terminals and containerized 5G RAN software as well as Header Compression software, announces today that it has licensed its ASN.1 5G Toolset and 5G gNB CU-UP software components to a leading provider of open and cloud-native 4G and 5G RAN software solutions. Effnet ASN.1 5G Toolset uses modern C++. It is portable, robust and provides high performance. It currently has support for ASN.1 in 3GPP Release 15 (RRC, F1AP, E1AP, NGAP, XnAP and NRPPa) specifications and the O-RAN E2AP specification. For more information, visit http://www.effnet.com/products/asn1/. Effnet 5G gNB CU-UP is a high quality and high-performance user plane software solution used in the Central Unit (CU) of a 5G gNB. Together with the Effnet...

(Santiago/Oslo, 12 April, 2021) Statkraft, Europe’s largest renewable energy generator, will build its first wind farms in Chile, expanding its renewable energy generation capacity in the South American country amid an increasing demand for hydro, wind and solar power in the southernmost nation in the world. Combined with the company’s existing hydropower assets, Statkraft will reach a generating capacity of 366 megawatt (MW) by the end of 2023. The 102 MW Torsa wind power project consists of three wind farms, totalling 19 wind turbines supplied by German manufacturer Nordex. In total, the wind farms are expected to produce more than 300 GWh of renewable energy annually; enough power to supply 100,000 average Chilean households. The project is located in the O’Higgins region, 124 kilometres south of the capital Santiago. “These three...

(Santiago/Oslo, 12. april 2021) Statkraft skal for første gang bygge vindkraftverk i Chile, og øker dermed sin produksjonskapasitet for fornybar energi i det søramerikanske landet, hvor etterspørselen etter vann-, vind- og solkraft er stigende. Sammen med selskapets eksisterende vannkraftportefølje i Chile, vil Statkraft nå en produksjonskapasitet på 366 megawatt (MW) innen utgangen av 2023. Det 102 MW store vindprosjektet Torsa består av tre vindparker, med til sammen 19 turbiner fra den tyske produsenten Nordex. Samlet forventes vindparkene å produsere mer enn 300 GWh med fornybar energi i året – nok til å forsyne 100.000 gjennomsnittlige chilenske hjem. Prosjektet ligger i O’Higgins-regionen, 124 kilometer sør for hovedstaden Santiago. – Disse tre vindparkene øker ikke bare vår produksjonskapasitet i Chile; de utvider vår fornybarportefølje...